2024
Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024
Reses H, Segovia G, Dubendris H, Barbre K, Ananth S, Lape-Newman B, Wong E, Stillions M, Rowe T, Mothershed E, Wallender E, Twentyman E, Wiegand R, Patel P, Benin A, Bell J. Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024. MMWR Morbidity And Mortality Weekly Report 2024, 73: 1052-1057. PMID: 39570790, PMCID: PMC11581205, DOI: 10.15585/mmwr.mm7346a2.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRespiratory syncytial virus vaccineNational Healthcare Safety NetworkSyncytial virusVaccination coverageSusceptible to severe outcomesHealth and Human Services regionsRespiratory virus seasonCOVID-19 vaccineCDC's National Healthcare Safety NetworkInfluenza vaccineVirus seasonSevere complicationsRespiratory virusesAssociated with respiratory illnessInfluenzaNursing home residentsSafety NetworkRespiratory illnessSevere outcomesReport vaccinationElevated riskSARS-CoV-2VaccineIndex levels
2023
Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, December 2023
Reses H, Dubendris H, Haas L, Barbre K, Ananth S, Rowe T, Mothershed E, Hall E, Wiegand R, Lindley M, Meyer S, Patel S, Benin A, Kroop S, Srinivasan A, Bell J. Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, December 2023. MMWR Morbidity And Mortality Weekly Report 2023, 72: 1371-1376. PMID: 38127673, PMCID: PMC10754267, DOI: 10.15585/mmwr.mm7251a3.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusNursing home residentsNational Healthcare Safety NetworkRespiratory virus seasonHome residentsVaccination coverageRespiratory virusesSyncytial virusCDC's National Healthcare Safety NetworkCOVID-19COVID-19 vaccination coverageHuman Services (HHS) regionsCOVID-19 vaccineSARS-CoV-2RSV vaccineSevere complicationsRespiratory illnessSevere outcomesNursing homesEligible residentsVaccinationInfluenzaSafety NetworkOlder adultsVaccine
2010
How Can We Communicate About Vaccines With Adolescents and Their Parents?
Benin AL, Wu AC, Holmboe ES, Shapiro ED, Anyan W. How Can We Communicate About Vaccines With Adolescents and Their Parents? Clinical Pediatrics 2010, 49: 373-380. PMID: 20118100, PMCID: PMC3773171, DOI: 10.1177/0009922809351091.Peer-Reviewed Original Research
2009
Veterans' attitudes to influenza vaccination in the setting of shortage of vaccine, 2004-2005
Benin AL, Learsy-Cahill D, Das R, Kancir S, Welch B, Martinello RA. Veterans' attitudes to influenza vaccination in the setting of shortage of vaccine, 2004-2005. Human Vaccines & Immunotherapeutics 2009, 5: 237-241. PMID: 18948733, DOI: 10.4161/hv.5.4.6808.Peer-Reviewed Original ResearchConceptsElderly veteransAdministration HospitalHigh-risk criteriaVeterans Administration HospitalProportion of veteransUnvaccinated participantsInfluenza vaccinationHigh riskVaccinationVeterans' attitudesVaccineInfluenzaVeteransMore participantsRandom sampleSmall proportionParticipantsAltruistic reasonsQualitative interviewsHospitalProportionUrgencyDose
2007
Postpartum Mothers’ Attitudes, Knowledge, and Trust Regarding Vaccination
Wu AC, Wisler-Sher DJ, Griswold K, Colson E, Shapiro ED, Holmboe ES, Benin AL. Postpartum Mothers’ Attitudes, Knowledge, and Trust Regarding Vaccination. Maternal And Child Health Journal 2007, 12: 766-773. PMID: 17987370, PMCID: PMC3344281, DOI: 10.1007/s10995-007-0302-4.Peer-Reviewed Original ResearchConceptsPostpartum mothersPrenatal careMajority of infantsBenefits of vaccinesCross-sectional studyLarge teaching hospitalLow family incomeVaricella vaccineMultivariable analysisTeaching hospitalWIC programChicken poxVaccinationVaccineImmunization informationWrong vaccineInfantsMothersChildren programFamily incomeCareTrusting relationshipPregnancyHospitalBabies
2006
Qualitative Analysis of Mothers' Decision-Making About Vaccines for Infants: The Importance of Trust
Benin AL, Wisler-Scher DJ, Colson E, Shapiro ED, Holmboe ES. Qualitative Analysis of Mothers' Decision-Making About Vaccines for Infants: The Importance of Trust. Pediatrics 2006, 117: 1532-1541. PMID: 16651306, DOI: 10.1542/peds.2005-1728.Peer-Reviewed Original ResearchConceptsVaccine-preventable diseasesPermanent side effectsThemes of trustMothers 1Open-ended interviewsSide effectsVaccinationLack of trustImportance of trustInfantsVaccineDays postpartumNew mothersCultural normsPediatriciansMothersChildrenVaccinatingCentral conceptInfluential personsTrusting relationshipSocial contactTrustQualitative analysisMedical profession
2005
Delivering Pneumococcal Vaccine to a High Risk Population: The Navajo Experience
Benin AL, Watt JP, O'Brien KL, Reid R, Zell ER, Katz S, Donaldson C, Schuchat A, Santosham M, Whitney CG. Delivering Pneumococcal Vaccine to a High Risk Population: The Navajo Experience. Human Vaccines & Immunotherapeutics 2005, 1: 66-69. PMID: 17038821, DOI: 10.4161/hv.1.2.1562.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedArizonaCross-Sectional StudiesDelivery of Health CareFemaleHumansImmunization ProgramsIndians, North AmericanMaleMiddle AgedNew MexicoPneumococcal InfectionsPneumococcal VaccinesPopulation SurveillanceRiskSample SizeUnited StatesUnited States Public Health ServiceUtahConceptsIndian Health ServiceVaccine indicationsVaccination programHealth servicesPneumococcal polysaccharide vaccineHealthy People 2010High-risk populationPublic health nursingCross-sectional studyNavajo adultsPneumococcal diseasePneumococcal vaccinePolysaccharide vaccineMedical chartsPreventable diseaseHealth nursingPersons 18Home visitsRisk populationsUniversal health insuranceExcellent delivery systemHealth insuranceNavajo patientsVaccineHigh rate
2004
Invasive Pneumococcal Disease among Navajo Adults, 1989–1998
Watt J, O'Brien K, Benin A, Whitney C, Robinson K, Parkinson A, Reid R, Santosham M. Invasive Pneumococcal Disease among Navajo Adults, 1989–1998. Clinical Infectious Diseases 2004, 38: 496-501. PMID: 14765341, DOI: 10.1086/381198.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal diseaseNavajo adultsPneumococcal diseaseEpidemiology of IPDRates of IPDPneumococcal polysaccharide vaccineCase fatality rateGeneral US populationPercent of casesBlack personsPolysaccharide vaccineAnnual incidenceActive surveillanceMedical recordsElevated riskPrevention strategiesUS populationDiseaseCorresponding ratesAdditional researchAdultsUnited StatesRiskPatientsVaccine
2003
Effectiveness of the 23-Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo Adults
Benin AL, O'Brien KL, Watt JP, Reid R, Zell ER, Katz S, Donaldson C, Parkinson A, Schuchat A, Santosham M, Whitney CG. Effectiveness of the 23-Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo Adults. The Journal Of Infectious Diseases 2003, 188: 81-89. PMID: 12825175, DOI: 10.1086/375782.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal diseaseOverall vaccine effectivenessNavajo adultsPneumococcal diseaseCase patientsControl patientsPolysaccharide vaccineVaccine effectivenessGeneral United States populationSerious pneumococcal diseasePneumococcal polysaccharide vaccineCohort methodologyUnited States populationCase-control setsActive surveillanceObservational studyMedical conditionsPatientsMedical careDiseaseAdultsDiabetesRegression analysisVaccineAlcoholism